Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients
Transplant Infectious Disease · 2024
DOI: 10.1111/tid.14282 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Christophe Camus und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Intensive Care, University Hospital of Rennes, Rennes, France. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Liver Transplantation, Antiviral Agents, Cytomegalovirus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Prophylaxis (P) or pre‐emptive strategy (PS) in high‐risk liver transplant recipients (LTRs) are either recommended. We compared the results of each strategy.
Methods
Two groups of LTR transplanted during two consecutive periods were compared. Only cytomegalovirus (CMV)‐mismatched LTR (Donor +/ Recipient ‐) were included. The primary endpoints were: the onset of polymerase chain reaction‐based DNAemia and the proportion of patients with CMV disease. A number of episodes of CMV infection, antiviral therapy, ganciclovir resistance, infectious or immunological complications, cost of both strategies, and survival (1, 5, and 10 years) were also compared.
Results
Forty‐eight and 60 patients were respectively included in the P and PS groups. Eighteen (38%) in the P group and 56 (93%) in the PS group had CMV DNAemia ( p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Intensive Care, University Hospital of Rennes, Rennes, France.
- CIC-INSERM 1414, University Hospital of Rennes and University of Rennes, Rennes, France.
- Department of Virology, University hospital of Rennes, Rennes, France.
- Department of liver transplantation, University Hospital of Rennes, Rennes, France.
- Laboratory BIOLARIS, Laval, France.
- Department of Hepatology, University Hospital of Dijon, Dijon, France.
ORCID-Profile: Matthieu Revest
Zitieren
APA
Camus, C., Poinot, M., Pronier, C., Rayar, M., Neillon, A. L., Latournerie, M., Lagathu, G., & Revest, M. (2024). Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients. Transplant Infectious Disease. https://doi.org/10.1111/tid.14282
Vancouver
Camus C, Poinot M, Pronier C, Rayar M, Neillon AL, Latournerie M, et al. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients. Transplant Infectious Disease. 2024. doi:10.1111/tid.14282
BibTeX
@article{Camus2024,
author = {Camus, Christophe and Poinot, Mélanie and Pronier, Charlotte and Rayar, Michel and Neillon, Anne Le and Latournerie, Marianne and Lagathu, Gisèle and Revest, Matthieu},
title = {Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients},
journal = {Transplant Infectious Disease},
year = {2024},
doi = {10.1111/tid.14282}
}
EUVIMED